483
Sentiss Pharma Pvt. Ltd.FDA 483 - Sentiss Pharma Pvt. Ltd. - May 23, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Geniss Pharma Pvt. Ltd., a sterile drug manufacturer in District Solan, India, was inspected by the FDA, revealing significant deficiencies. The inspection highlighted inadequate investigations into discrepancies and data integrity issues, failures in aseptic processing procedures, and a lack of proper quality control and change control. Laboratory controls were also found to be deficient, with issues in specifications, testing, and record-keeping.
Open in Dashboard
ID · 82a7a1be-a10d-471d-92f0-f20ac54177e7